Matthew Foy
Directeur/Membre du Conseil chez Akamis Bio Ltd.
Provenance du réseau au premier degré de Matthew Foy
Entité | Type d'entité | Industrie | |
---|---|---|---|
Public Company | Investment Banks/Brokers | 72 | |
GSK Equity Investments Ltd.
GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California.
20
| Subsidiary | Investment Managers | 20 |
SR One Capital Management LP
SR One Capital Management LP Investment ManagersFinance SR One Capital Management LP (SR One) is a venture capital firm founded in 2020. The firm is headquartered in Redwood, California.
18
| Private Company | Investment Managers | 18 |
Asceneuron SA
Asceneuron SA Pharmaceuticals: MajorHealth Technology Asceneuron SA operates as a biotechnology company. It develops therapeutics for orphan tauopathis and Alzheimer?s disease. The firm specializes in small molecule drug discovery for neurodegenerative diseases. The company was founded by Dirk Beher, Frank Murdoch Armstrong and Christoph Wiessner in October 2012 and is headquartered in Lausanne, Switzerland.
15
| Holding Company | Pharmaceuticals: Major | 15 |
Fore Biotherapeutics, Inc.
Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA.
13
| Holding Company | Pharmaceuticals: Major | 13 |
Pulmocide Ltd.
Pulmocide Ltd. Pharmaceuticals: MajorHealth Technology Pulmocide Ltd. provides biopharmaceutical services. It develops inhaled medicines for viral and fungal infections of the respiratory tract. The company was founded by William Garth Rapeport, John Murray, Kazuhiro Ito, and Peter Strong on March 23, 2007 and is headquartered in London, the United Kingdom.
12
| Holding Company | Pharmaceuticals: Major | 12 |
Akamis Bio Ltd.
Akamis Bio Ltd. BiotechnologyHealth Technology Akamis Bio Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom.
7
| Holding Company | Biotechnology | 7 |
Progenitor Labs Ltd.
Progenitor Labs Ltd. Pharmaceuticals: MajorHealth Technology Progenitor Labs Ltd. develops drugs to regenerate specific tissues of the human body in response to injury, disease, and ageing. Its products include ProScreen and CombiCult. The company was founded by Yen Choo on February 12, 2010 and is headquartered in Stevenage, the United Kingdom.
3
| Holding Company | Pharmaceuticals: Major | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Matthew Foy via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Consultant / Advisor Corporate Officer/Principal President | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
CONCERT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Director/Board Member | |
AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal | |
PRINCIPIA BIOPHARMA INC. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Chief Operating Officer | |
NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
University of Virginia | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin Graduate Degree | |
Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree | |
Duke University
Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree Masters Business Admin Undergraduate Degree Undergraduate Degree | |
Stanford University | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree Doctorate Degree | |
University of Pennsylvania | College/University | Corporate Officer/Principal Masters Business Admin Masters Business Admin Masters Business Admin | |
University of Oxford | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
IP GROUP PLC | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
GCP Capital Partners LLC
GCP Capital Partners LLC Investment ManagersFinance GCP Capital Partners LLC (GCP Capital Partners) is a private equity subsidiary of GCP Capital Partners Holdings LLC founded in 2000. The firm is headquartered in New York. | Investment Managers | Founder General Counsel Private Equity Investor | |
University of Cambridge | College/University | Doctorate Degree Doctorate Degree Graduate Degree | |
Yale University | College/University | Graduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree | |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Director/Board Member Masters Business Admin Undergraduate Degree Undergraduate Degree | |
New York University | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
ADDEX THERAPEUTICS LTD | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
University College London | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
RespiVert Ltd.
RespiVert Ltd. Medical DistributorsDistribution Services RespiVert Ltd. operates as a small molecule drug discovery company. The firm develops small-molecule inhaled therapies for the treatment of chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis. The company was founded by William Garth Rapeport, Peter Strong, Kazuhiro Ito, John Murray and Peter Barnes in 2007 and is headquartered in London, the United Kingdom. | Medical Distributors | Director/Board Member Director/Board Member Founder Founder | |
BICYCLE THERAPEUTICS PLC | Biotechnology | Director/Board Member Director/Board Member | |
ORPHAZYME A/S | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal | |
Lilly Oncology
Lilly Oncology Hospital/Nursing ManagementHealth Services Part of Eli Lilly & Co., Lilly Oncology is an American company dedicated to delivering life-changing medicines and support to people living with cancer and those who care for them. With over 50 years of experience, Lilly Oncology is committed to building on their heritage and improving the lives of all those affected by cancer worldwide. | Hospital/Nursing Management | Corporate Officer/Principal Corporate Officer/Principal | |
Second Genome, Inc.
Second Genome, Inc. BiotechnologyHealth Technology Second Genome, Inc. develops microbiome-based therapeutic products. It offers phyclochip community, 16S sequencing community analysis, whole metagenomic profiling, nucleic acid isolation, inferred function and custom informatics services. The company was founded in 2009 by Corey S. Goodman, Janet A. Warrington, Todd Z. DeSantis, John Hulls and Gary Andersen and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member | |
VERASTEM, INC. | Biotechnology | Chief Executive Officer Corporate Officer/Principal | |
The University of North Carolina at Charlotte | College/University | Undergraduate Degree Graduate Degree | |
Galecto Biotech ApS
Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Amphivena Therapeutics, Inc.
Amphivena Therapeutics, Inc. Drugstore ChainsRetail Trade Amphivena Therapeutics, Inc. provides drug discovery services. It develops tetravalent, T-cell redirecting bispecific antibodies for the treatment of hematologic malignancies. The firm’s’ lead drug candidate is AMV-564, a CD33/CD3-targeting treatment for acute myeloid leukemia (AML), which Amphivena is currently preparing to advance into clinical development. The company was founded by Jeanmarie Guenot in December 2012 and is headquartered in San Francisco, CA. | Drugstore Chains | Chairman Director/Board Member | |
The Wharton School of the University of Pennsylvania | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Undergraduate Degree | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
CRISPR THERAPEUTICS AG | Biotechnology | Chief Executive Officer Director/Board Member | |
Gladius Pharmaceuticals Corp.
Gladius Pharmaceuticals Corp. BiotechnologyHealth Technology Gladius Pharmaceuticals Corp. operates as a biotechnology firm. The company is headquartered in Wilmington, DE. | Biotechnology | Director/Board Member Director/Board Member | |
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
STORM Therapeutics Ltd.
STORM Therapeutics Ltd. BiotechnologyHealth Technology Storm Therapeutics Ltd. develops small molecule drugs that target RNA-modifying enzymes. It offers research and development of drug molecules for the treatment of specific cancers. The company was founded by Anthony Kouzarides and Eric Miska on April 21, 2015 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member | |
HotSpot Therapeutics, Inc.
HotSpot Therapeutics, Inc. BiotechnologyHealth Technology HotSpot Therapeutics, Inc. develops new allosteric therapies with the ability to treat disease. The company was founded by Jonathan Montagu and Geraldine Harriman and is headquartered in Boston, MA. | Biotechnology | Director/Board Member Director/Board Member | |
True North Therapeutics, Inc.
True North Therapeutics, Inc. BiotechnologyHealth Technology True North Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of first-in-class product candidates for complement-mediated diseases. The company was founded by Nancy E. Stagliano in 2013 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Founder Chief Executive Officer | |
Comet Therapeutics, Inc.
Comet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Comet Therapeutics, Inc. develops and commercializes treatments for patients suffering from metabolic, neurological and immunological disorders. The company was founded by Angellina Sekirnik and Enej Kuscer in 2008 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
MiroBio Ltd.
MiroBio Ltd. BiotechnologyHealth Technology Mirobio Ltd. operates as a biologics company focusing on autoimmune and inflammatory disorders. The firm develops antibody modulators of immune cell receptors, an approach that has potential across a range of diseases, with an initial focus on auto-immune disease. The company was founded by Richard Cornall and Simon Davis on October 8, 2018 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member Chairman | |
Vasomune Therapeutics, Inc.
Vasomune Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Vasomune Therapeutics, Inc. operates as an early stage biopharmaceutical company. It develops medicines to harness the body’s ability to defend against illness by modifying cellular response to disease. The company is headquartered in Toronto, Canada. | Pharmaceuticals: Other | Director/Board Member Director/Board Member |
Statistiques
Internationale
Etats-Unis | 35 |
Royaume-Uni | 9 |
Suisse | 4 |
Danemark | 3 |
Israël | 2 |
Sectorielle
Health Technology | 28 |
Consumer Services | 17 |
Commercial Services | 3 |
Finance | 2 |
Distribution Services | 2 |
Opérationnelle
Director/Board Member | 636 |
Corporate Officer/Principal | 215 |
Independent Dir/Board Member | 118 |
Chairman | 88 |
Private Equity Investor | 80 |
Relations les plus connectées
Insiders | |
---|---|
Tomer Kariv | 46 |
Stephen Knight | 39 |
Christoph Westphal | 32 |
Dieter Weinand | 32 |
Kate Bingham | 31 |
Erez Chimovits | 30 |
Mette Agger | 30 |
Catherine Moukheibir | 29 |
Steve B. Brotman | 29 |
Daniel Burgess | 28 |
Samuel Cameron Williams | 27 |
Deborah Harland | 27 |
Jens Eckstein | 27 |
Rajeev Dadoo | 24 |
Jake Bauer | 24 |
- Bourse
- Insiders
- Matthew Foy
- Connexions Sociétés